Valuation (36%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 26,857.90 | 25.33 |
| PEG Ratio (TTM) | -279.77 | 4.60 |
| P/S Ratio (TTM) | 3.83 | 4.86 |
| P/B Ratio (TTM) | 1.59 | -14.11 |
| P/FCF Ratio (TTM) | 65.72 | 35.08 |
| Price to 5YR AVG Earnings Ratio | 0.11 | 7.20 |
| Price to 5YR AVG FCF Ratio | -7.38 | 74.01 |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.00% | 6.69% |
| ROE (TTM) | 0.01% | 166.93% |
| Net Profit Margin (TTM) | 0.01% | 9.86% |
| ROIC 5YR AVG | 3.58% | 10.70% |
Growth (63%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -118.89% | 755.86% | 422.01% |
| Revenue | 2.75% | -21.87% | -6.75% |
| Net Income | -119.61% | 2,996.59% | 1,766.92% |
| Cash Flow | 639.50% | 1,152.06% | 724.42% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.28 | 1.21 |
| Quick Ratio (TTM) | 1.16 | 1.16 |
| D/E Ratio (TTM) | 0.92 | -3.31 |
| Interest Coverage (TTM) | 1.23 | 12.78 |
| Piotroski F-Score | 5 | 6 |
| Altman Z-Score | 1.06 | 4.84 |
| LTL to 5YR AVG FCF | -4.84 | 10.34 |
| Shares Outstanding Growth 5YR AVG | 1,757.25% | 4.27% |